Literature DB >> 24259239

Acute mental status change as the presenting feature of adrenal insufficiency in a patient with autoimmune polyglandular syndrome type II and stroke.

Sara Watson, Shekar Raj, Erica Eugster, Juan Sanchez.   

Abstract

Primary adrenal insufficiency (AI) in children usually presents with non-specific symptoms such as fatigue, nausea, vomiting, and anorexia. Here, we report an unusual case of a 15 year old girl who presented with acute mental status change and was ultimately diagnosed with AI due to autoimmune polyglandular syndrome type II (APS2). Central nervous system imaging revealed a cerebral infarction. To our knowledge, the constellation of APS2, stroke and acute mental status change has not been previously reported. We review the literature with regard to the presentation of AI as well as the association between vasculitis and APS2.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24259239      PMCID: PMC4063523          DOI: 10.1515/jpem-2013-0201

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  12 in total

1.  Microscopic polyarteritis with antineutrophil cytoplasmic antibodies in polyglandular autoimmunity.

Authors:  M Bonomini; N Settefrati; A Uncini; A Di Muzio; A Albertazzi
Journal:  Nephrol Dial Transplant       Date:  1998-03       Impact factor: 5.992

2.  The neuropsychiatric aspect of Addison's disease: a case report.

Authors:  Mohamed Abdel-Motleb
Journal:  Innov Clin Neurosci       Date:  2012-10

3.  Recurrent macular edema and stroke syndrome in type 1 diabetes mellitus with potent endothelial cell inhibitory autoantibodies.

Authors:  Mark B Zimering
Journal:  Endocr Pract       Date:  2010 Sep-Oct       Impact factor: 3.443

4.  Anti-neutrophil cytoplasmic antibody (ANCA) associated small-vessel vasculitis in a patient with diabetic nephropathy and autoimmune polyendocrinopathy syndrome (APS) Type 2: a case report.

Authors:  Jonathan S Murray; Laura A Baines; Simon H S Pearce; Steve Ball; Nicola Leech; Katrina M Wood; Nigel S Kanagasundaram
Journal:  Clin Nephrol       Date:  2013-09       Impact factor: 0.975

5.  Thyroxine unmasks Addison's disease.

Authors:  M G Shaikh; P Lewis; J M W Kirk
Journal:  Acta Paediatr       Date:  2004-12       Impact factor: 2.299

6.  Presentation of primary adrenal insufficiency in childhood.

Authors:  Susan Hsieh; Perrin C White
Journal:  J Clin Endocrinol Metab       Date:  2011-04-06       Impact factor: 5.958

7.  Addisonian crisis precipitated by thyroxine therapy: a complication of type 2 autoimmune polyglandular syndrome.

Authors:  Leland Graves; Robert M Klein; Anne D Walling
Journal:  South Med J       Date:  2003-08       Impact factor: 0.954

8.  Unusual presentation of Addison's disease in Schmidt's syndrome.

Authors:  A Gaiero; R Mulas; S Zecca; G Fichera; A Cohen
Journal:  J Pediatr Endocrinol Metab       Date:  2003-06       Impact factor: 1.634

9.  Rare autosomal dominant POLG1 mutation in a family with metabolic strokes, posterior column spinal degeneration, and multi-endocrine disease.

Authors:  Sarah E Hopkins; Arthur Somoza; Donald L Gilbert
Journal:  J Child Neurol       Date:  2009-10-08       Impact factor: 1.987

10.  Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: a case-control study.

Authors:  Sofia Lionaki; Susan L Hogan; Ronald J Falk; Melanie S Joy; Hyunsook Chin; Caroline E Jennette; J Charles Jennette; Patrick H Nachman
Journal:  Nephrol Dial Transplant       Date:  2007-08-08       Impact factor: 5.992

View more
  2 in total

1.  Isolated cortical vein thrombosis in autoimmune polyglandular syndrome type 2.

Authors:  Paloma Gonzalez-Perez; Marcelo Correia; Aristides A Capizzano; Harold P Adams
Journal:  Neurology       Date:  2016-03-02       Impact factor: 9.910

2.  Deep vein thrombosis, an unreported first manifestation of polyglandular autoimmune syndrome type III.

Authors:  M Horsey; P Hogan; T Oliver
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2016-07-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.